Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique
- 14 September 2005
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 48 (10), 1988-1995
- https://doi.org/10.1007/s00125-005-1916-y
Abstract
This single-dose, double-blind, randomised, parallel-group study evaluated the reproducibility in systemic exposure and glucodynamic effect of insulin glargine, NPH insulin (NPH) and insulin ultralente (ultralente) using the manually adjusted euglycaemic clamp technique.Keywords
This publication has 19 references indexed in Scilit:
- Reduced Hypoglycemia Risk With Insulin GlargineDiabetes Care, 2005
- Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 DiabetesDiabetes, 2004
- The Treat-to-Target TrialDiabetes Care, 2003
- Negotiating the Barrier of Hypoglycemia in DiabetesDiabetes Spectrum, 2002
- The euglycemic hyperinsulinemic clamp examination: variability and reproducibilityScandinavian Journal of Clinical and Laboratory Investigation, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The pharmacokinetic basis of insulin therapy in diabetes mellitusDiabetes Research and Clinical Practice, 1989
- Assessment of insulin sensitivity in vivo: A critical reviewDiabetes/Metabolism Research and Reviews, 1989
- A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clampingDiabetologia, 1984